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Summary
Glutamate transport is highly regulated as glutamate directly
acts as a neurotransmitter [1–3] and indirectly regulates the
synthesis of antioxidants [4, 5]. Although glutamate deregu-
lation has been repeatedly linked to serious human diseases
such as HIV infection and Alzheimer’s [6–8], glutamate’s role
in the immune system is still poorly understood.We find that
aputativeglutamate transporter inDrosophilamelanogaster,
polyphemus (polyph), plays an integral part in the fly’s
immune response. Flieswith a disruptedpolyphgene exhibit
decreased phagocytosis of microbial-derived bioparticles.
When infected with S. aureus, polyph flies show an increase
in both susceptibility and bacterial growth. Additionally, the
expression of two known glutamate transporters, gender-
blind and excitatory amino acid transporter 1, in blood cells
affects the flies’ ability to phagocytose and survive after an
infection. Consistent with previous data showing a regula-
tory role for glutamate transport in the synthesis of themajor
antioxidant glutathione, polyph flies produce more reactive
oxygen species (ROS) as compared to wild-type flies when
exposed to S. aureus. In conclusion, we demonstrate that a
polyph-dependent redox system in blood cells is necessary
to maintain the cells’ immune-related functions. Further-
more, our model provides insight into how deregulation of
glutamate transport may play a role in disease.
Results and Discussion
The Putative Amino Acid Transporter polyph Is Required in
Blood Cells for Phagocytosis of Microbes
From a genetic screen, we identified a transposon line, Mi[ET1]
CG12943MB02238, with a striking defect in phagocytosis. The
disrupted gene, CG12943 (Figure 1A), is predicted to contain
an amino acid transmembrane transporter domain and be
related to Drosophila excitatory amino acid transporter
1(eaat1) with w20% amino acid similarity. CG12943 was
namedpolyphemus (polyph) after theCyclops inGreekmythol-
ogy who failed to guard against Odysseus as polyph flies are
similarly unable to defend against an intruding microbe.
The phagocytic capacity of polyph flies wasmeasured using
an in vivo adult phagocytosis assay [9]. Flies are injected with
fluorescently labeled bioparticles. The amount of fluorescence
in the dorsal vessel areawhere sessile phagocytes accumulate
is visualized and quantified (Figure 1B). polyph flies were defi-
cient in phagocytosis of S. aureus (Figure 1C), E. coli (Fig-
ure 1D), and zymosan (data not shown), while phagocytosis*Correspondence: lwu1@umd.eduof latex beads was normal (Figure 1E). polyph flies do not
have fewer blood cells (Figure S3B available online), which in-
dicates that polyph flies have adequate numbers of blood cells
with functional phagocytic machinery. Hence, the defect in
polyph is specific to the inability to phagocytose microbial-
derived bioparticles.
Drosophila blood cells can circulate in larvae, while in adult
flies they become mainly sessile and difficult to separate from
the surrounding tissue [10]. Therefore, blood cell expression of
polyph was measured by collecting larval hemolymph which
includes circulating blood cells. FlyAtlas does not examine
gene expression in the blood cells, but did report an enriched
expression of polyph in the testes [11], so the sexes were eval-
uated separately.
In females, the blood cells have an enriched polyph expres-
sion compared to the carcass (Figure S1A).Males also express
polyph in their blood cells, with similar levels in their carcass
presumably due to testes expression. Adult polyph expression
was measured in whole animals. Male expression of the gene
was higher than in females, but neither sex showed significant
upregulation with S. aureus infection. Immunostaining of Flag-
tagged Polyph protein confirmed that the putative amino acid
transporter localized to the plasma membrane consistent with
a role in phagocytosis (Figure S1B).
As blood cells are a major source of polyph mRNA, an
RNAi construct against polyph was specifically expressed in
blood cells (Figure S2A), which recapitulated the decrease in
S. aureus phagocytosis observed in the original mutant (Fig-
ure S2B). Furthermore, the phagocytosis defect in the original
mutant could be rescued by expressing polyph in blood cells
(Figure 2A), confirming that the defect is due to a lack of polyph
expression in blood cells.
polyph Flies Have Decreased Resistance to an S. aureus
Infection
polyph flies showed increased susceptibility to S. aureus
infection (Figures 2B and 2C), which could be rescued by
expression of polyph in blood cells (Figure 2D). This suscepti-
bility was substantiated by expression of RNAi against the
gene specifically in blood cells (Figure S2C). The gene is likely
playing a role in resistance rather than tolerance, as there is an
increased bacterial load in polyph flies as compared to wild-
type files (Figure 2E). Blood-cell-specific expression of the
gene rescues the bacterial growth indicating that polyph is
required in the blood cells to control the growth of bacteria
during an infection (Figure 2F).
As Polyph is predicted to be an amino acid transporter, the
loss of this protein may be affecting fly growth either directly
or through a nutrient-sensing mechanism. However, there was
no difference in weight compared to thewild-type (Figure S3C).
Additionally, polyph flies are not generally weak as they are not
more susceptible to wounding (Figures 2B and 2C), being kept
at 30C (Figure S3A), or an E. coli infection (data not shown).
polyphDoesNot Play aRole in the Induction of drosomycin
or diptericin
When activated by microbes, the Toll and Imd pathways upre-
gulate the production of antimicrobial peptides (AMPs), which
Figure 1. polyph, a Putative Amino Acid Trans-
porter, Is Required for Microbial Phagocytosis
(A) Comparison of polyph transcript levels via
quantitative PCR in wild-type flies (WT) and flies
containing a transposon insertion in the polyph
gene (polyph). Relative expression was mea-
sured using rp49 as an endogenous control. A
pool of ten flies per genotype was used in each
experiment.
(B) Representation of how the fly is visualized
during the in vivo adult phagocytosis assay.
The encircled area represents the area of the
dorsal vein around which the sessile blood cells
congregate.
(C–E) Representative pictures depicting phago-
cytosis in WT and polyph flies of fluorescein-
labeled S. aureus bioparticles (C), fluorescein-
labeled E. coli bioparticles (D), and red
fluorescently labeled latex beads (E). Approxi-
mately six flies per genotype were used in each
experiment. Quantification follows.
Error bars indicate 6SE. **p < 0.01; ***p < 0.001.
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infection strongly induces drosomycin, while E. coli causes a
comparatively weak induction. The opposite is true with dip-
tericin. When infected with either S. aureus or E. coli, polyph
flies showed normal induction of both drosomycin and dipter-
icin, which are primarily upregulated by the Toll and Imd path-
ways, respectively [12, 13] (Figures S2D and S2E). Hence,polyph does not play a major role in
either of these pathways, consistent
with data showing no effect on another
AMP, defensin, when phagocytosis of
S. aureus is decreased [14]. It appears
that polyph’s primary role is modulating
the cellular immune response.
polyph Flies Exhibit Increased ROS
and Decreased Bead Phagocytosis
when Exposed to S. aureus
According to HomoloGene, polyph is
closely related to eaat1, a glutamate
transporter in the central nervous sys-
tem [15, 16]. Eaats transport extracel-
lular glutamate into the cell using a
sodium/potassium exchange system
[17]. The other major branch of gluta-
mate transporters, the X2c transporters,
exchanges a cystine for a glutamate in
a sodium-independent process. The
direction of exchange is concentration
dependent [18]. Normally, there is
more glutamate inside the cell than
outside, with the inverse being true for
cystine, thus causing the antiporter to
exchange an intracellular glutamate for
an extracellular cystine. Once inside
the cell, cystine is reduced to cysteine,
the limiting reagent in glutathione
(GSH) synthesis [4, 18]. GSH acts as a
major antioxidant in the cell by reducing
reactive oxygen species (ROS) [19].
Therefore, we measured ROS levels in
polyph flies using the substrate CM-H2CDFDA, which becomes fluorescent when oxidized. When
flies were first injected with PBS, followed by the substrate,
polyph showed no significant difference in ROS levels as
compared to the wild-type. However, when flies were first
exposed to S. aureus and then injected with the substrate,
polyph flies made significantly more ROS than did wild-type
files (Figure 3A). For determination of whether exposure to
Figure 2. polyph Flies Have Decreased Resis-
tance against an S. aureus Infection
(A) Quantification of the phagocytosis of fluores-
cein-labeled S. aureus bioparticles in hml/WT,
polyph, and polyph; hml>polyph flies. Approxi-
mately six flies per genotype were used in each
experiment.
(B and C) Representative survival curves of male
(B) and female (C) WT and polyph flies after
injection of S. aureus (optical density [OD] 0.5).
n = 24–30 flies. Experiments were performed in
triplicate.
(D) Representative survival curve of WT, polyph,
hml/WT, and polyph; hml>polyph flies after injec-
tion of S. aureus (OD 0.5). The WT flies have
polyph’s genetic background, while hml/WT flies
have the same genetic background as the rescue
flies in which polyph expression is driven by
hmlDGAL4. n = 28–30 flies. Experiments were
performed in triplicate.
(E) Comparison of the S. aureus (OD 0.5) recov-
ered in WT and polyph flies 0, 18, and 24 hr post-
infection. Bacterial load was measured in eight
individual flies per genotype at each time point
in each experiment. The experiment was per-
formed in quadruplicate.
(F) Comparison of the S. aureus (OD 0.5) recov-
ered in WT, polyph, hml/WT, and polyph;
hml>polyph flies 0 and 24 hr postinfection. Three
replicate experiments were performed.
Error bars indicate 6SE. *p < 0.05; ns, not signif-
icantly different.
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2321S. aureus causes an increase of ROS specifically in polyph
blood cells, larval hemolymph was bled into PBS and incu-
bated with CM-H2CDFDA and S. aureus ex vivo. These exper-
iments were done with larval-derived hemolymph because of
the difficulty collecting adult hemocytes poses. At 30 min,
there was no difference between ROS levels in wild-type and
polyph files, indicating that polyph flies do not have a higher
basal level of ROS. However, after 90 min, the ROS levels in
polyph flies were significantly higher than that in wild-type flies
(Figure 3B).
The increase in ROS corresponds with a decrease in polyph
flies’ phagocytic capacity upon exposure to S. aureus. When
flies are injected with PBS and then latex beads, polyph flies
show a phagocytic capacity equal to wild-type flies. How-
ever, when flies were preinjected with S. aureus, polyph flies
take up significantly less latex beads than wild-type flies
(Figure 3C). To examine whether polyph flies have a more
limited phagocytic capacity that is overwhelmed by the double
injection of bacteria and beads, we injected flies with yellow/
green fluorescent beads and then red fluorescent beads.
polyph flies were able to uptake the red beads in a manner
indistinguishable from wild-type flies (Figure S3E). Hence,
polyph flies do not have a more limited phagocytic capacity
but instead become unable to phagocytose upon exposure
to S. aureus.
To confirm that glutamate metabolism and ROS affect
phagocytosis, we examined the role of glutamine synthe-
tase-1 (GS1). GS1 converts glutamate and ammonia into gluta-
mine and regulates ROS production by decreasing glutamate
levels [20, 21]. Drosophila GS1 also regulates ROS, as fliesexpressing gs1 RNAi in blood cells
have more ROS after infection with
S. aureus (Figure S3F). gs1 flies haveimpaired phagocytosis of S. aureus like polyph (Figure 3D),
confirming that glutamate misregulation and increased ROS
are associated with decreased phagocytosis.
polyph Flies Are Less Susceptible to the Intracellular
Pathogen Listeria monocytogenes
L. monocytogenes is a facultative intracellular pathogen
capable of invading phagocytic cells and subsequently
escaping from the phagosome [22]. The bacteria then suc-
cessfully replicate within the phagocyte and spread to other
cells throughout the organism. Interestingly, polyph flies
are less susceptible to an L. monocytogenes infection as
compared to wild-type flies (Figure 3E). It is possible that the
decreased phagocytosis and increased ROS result in reduced
bacterial loads, allowing polyph flies to fight off infection more
effectively than wild-type flies.
Phagocytosis Is Affected when Amino Acid Transport Is
Either Blocked or Modulated in Blood Cells
As normal glutamate transport is essential for healthy nerve
function, multiple drugs have been developed to modulate
glutamate transport. Threo-beta-hydroxyaspartate (THA), an
aspartate analog, acts as a general inhibitor of eaat trans-
porters [4]. Hemolymph was collected from wild-type larvae,
and after addition of either PBS or THA, the blood cells were
assayed for uptake of S. aureus. Blood cells incubated with
THA showed significantly less phagocytosis than the blood
cells in PBS (Figure 4A), indicating that blocking glutamate
transport in wild-type blood cells inhibits phagocytosis. This
was supported by measurement of the phagocytic capacity
Figure 3. polyph Has Increased ROS in Its
Hemolymph and Decreased Phagocytosis when
Exposed to Bacteria
(A) Representative pictures of oxidized CM-
H2CDFDA-derived fluorescence in WT and
polyph flies after a 30 min preinjection of either
PBS or overnight culture of S. aureus. Approxi-
mately six flies were used per genotype in each
experiment. Quantification follows.
(B) Measurement of oxidized CM-H2CDFDA-
derived fluorescence in WT and polyph blood
cells incubated ex vivo with an overnight
S. aureus culture.
(C) Quantification of the phagocytosis of red
fluorescently labeled latex beads in WT and
polyph flies after a 30 min preinjection of either
PBS or overnight culture of S. aureus. Approxi-
mately six flies per genotype were used in each
experiment.
(D) Quantification of the phagocytosis of fluores-
cein-labeled S. aureus bioparticles in WT/gs1
RNAi and hml>gs1 RNAi. Approximately six flies
per genotype were used in each experiment.
(E) Representative survival curve of WT and
polyph flies after injection of L. monocytogenes
(OD 0.1). n = 28–30 flies.
All experiments were done in triplicate. Error bars
indicate 6SE. *p < 0.05.
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2322of cells in minimal media with glutamate, cystine, or both
added. Cells showed significantly less phagocytosis when
incubated with only glutamate and consistently more (albeit
not significant, p = 0.061) when given cystine (Figure 4B).
The base minimal media contained an extremely small
amount of cystine (0.099 mM) and no glutamate. When excess
glutamate was added extracellularly, this mimicked the
presumed situation of polyph cells. By artificially forcing a
high [glutamate]extracellular and a low [glutamate]intracellular, this
drives the glutamate/cystine antiporter to pump glutamate
into the cell and cystine out, thereby depleting the cells’ store
of cystine and preventing them from making GSH. Without
their ability to counteract bacteria-induced ROS, it is possible
that the cells become unable to phagocytose efficiently. In
contrast, when cells are given high levels of cystine, this drives
the antiporter in the canonical direction, allowing the cell to
continually make more GSH. These data indicate that gluta-
mate transport into blood cells is a tightly regulated process
that is necessary for blood cells to remain effective against
an infection.Other Amino Acid Transporters,
when Expressed in Blood Cells, Play
a Similar Role in the Immune
Response as polyph
Glutamate, an important neurotrans-
mitter, plays a complicated role in gluta-
mate toxicity, a phenomenon where
neurons become sick from increased
intracellular ROS due to excess extra-
cellular glutamate [23, 24]. The gluta-
mate/cystine antiporter is concentration
dependent, so if eaat1 is functioning
properly, there is more intracellular
glutamate than extracellular, driving
glutamate out and cystine in [18].
However, if eaat1 or the glutamate/cystine antiporter, genderblind (gb), is mutated, then cystine
is no longer transported in, GSH is limited, and ROS rises.
The role of gb in glutamate transport and GSH synthesis is
well established [25]. gb larvae had significantly less glutamate
in their hemolymph compared to wild-type larvae [26]. How-
ever, the role of gb in an immunological response was un-
known. We examined whether eaat1 or gb was expressed on
blood cells and whether mutants showed phenotypes similar
to polyph.
gb (Figure S1C), but not eaat1 (Figure S1D), was expressed
in blood cells. Consistent with this, gb mutants showed
both increased susceptibility to S. aureus infection and
decreased phagocytosis of S. aureus, whereas eaat1 mu-
tants did not (Figures 4C–4E). Conversely, to determine
whether polyph plays a role in the CNS, we performed
a climbing assay. When knocked down, flies will instinc-
tively climb upward. eaat1 mutants have a motor defect
due to inefficient glutamate transport in their CNS, and they
climb more slowly than wild-type flies [15]. This motor defect
was observed in eaat1 but not in polyph flies (Figure S3D),
Figure 4. Survival andPhagocytosis Are Affected
when Blood Cell Amino Acid Transport Is
Modulated
(A and B) Wild-type blood cells in hemolymph
were incubated ex vivo with fluorescein
S. aureus bioparticles in PBS or 5 mM THA
(A) or media plus nothing, glutamate, cystine,
or glutamate and cystine (B). After 30 min, the
number of bioparticles/cell was counted in
approximately 20 cells per group in each ex-
periment.
(C) Representative survival curves of WT, gb, and
eaat1 flies after injection of S. aureus (OD 0.05).
n = 30 flies.
(D–F) Quantification of the phagocytosis of
fluorescein-labeled S. aureus bioparticles in
WT and gb flies (D), WT and eaat1 flies (E), and
WT, polyph, hml/WT, and polyph; hml>eaat1
flies (F).
Approximately six flies per genotype were
used in each experiment. All experiments were
performed at least in triplicate. Error bars
indicate6SE. *p < 0.05; **p < 0.01; ns, not signif-
icantly different.
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vous system.
If Polyph is functioning in a similar manner to Eaat1 but in a
different tissue, then blood-cell-specific expression of eaat1 in
a polyph mutant background should rescue the phenotypes
seen in polyph flies. There is indeed strong rescue of the
phagocytosis phenotype in polyph; hml>eaat1 flies (Figure 4F).
These data indicate that Polyph is an important glutamate
transporter expressed on blood cells. It works with the
cystine/glutamate antiporter Gb to control internal ROS in
order to maintain macrophage function. Our model (MovieS1) indicates that polyph flies have
increased extracellular glutamate in
their hemolymph due to an inability to
effectively transport it into the cell.
This leads to a decrease in GSH and
an increase in internal ROS. Without
tight regulation of glutamate transport
across the blood cell membrane, the
fly loses its resistance to a pathogenic
infection due to a decrease in phago-
cytic capacity.
With an unbalanced GSH redox sys-
tem, there is potential for human
disease. People with a glutathione
reductase deficiency have impaired
neutrophil function. When the anti-
oxidant GSH reduces ROS, it is
converted into its oxidized state, gluta-
thione disulfide (GSSG). Glutathione
reductase facilitates conversion of
GSSG back to its reduced state, GSH.
Without the enzyme, the redox system
skews toward the oxidized state and
is less able to reduce free reactive
species. Neutrophils from individuals
with the genetic disorder could main-
tain normal levels of ROS for a short
period of time, but not after an
extended incubation with bacteria[27]. These findings support our model and show that under-
standing the delicate balance of this system has relevance
to human disease. Additionally, increased glutamate levels
in the plasma have been associated with other diseases,
including amyotrophic lateral sclerosis [28], epilepsy [29],
stroke-associated headache [30], HIV-associated dementia
[31], Parkinson’s disease [32], breast cancer, colorectal carci-
noma, and AIDS [33]. Our results demonstrate that a tightly
regulated redox system in the blood cells is necessary to
maintain immune cell function and therefore for the health
of the whole organism.
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